Adjuvant intraoperative photodynamic therapy in head and neck cancer

JAMA Otolaryngology - Head and Neck Surgery

Volumn 139, Issue 7, 2013, Pages 706-711

  Rigual, Nestor R ^a   Shafirstein, Gal ^a   Frustino, Jennifer ^b   Seshadri, Mukund ^a   Cooper, Michele ^a   Wilding, Gregory ^a   Sullivan, Maureen A ^a   Henderson, Barbara ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (1 HEXYLOXYETHYL) 2DEVINYL PYROPHEOPHORBIDE A; PHEOPHORBIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUDITORY CANAL; BURN; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; EDEMA; FEMALE; FISTULA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEART INFARCTION; HUMAN; LARYNX CANCER; LASER; LIGHT; MALE; MANDIBLE FRACTURE; MOUTH CAVITY; OPERATING ROOM; OROPHARYNX; PHASE 1 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PHOTOPHOBIA; PHOTOTOXICITY; PRIMARY TUMOR; PULSE RATE; TUMOR BIOPSY; WOUND INFECTION;

AGED; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CHLOROPHYLL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INTRAOPERATIVE CARE; LASERS; MALE; PHOTOCHEMOTHERAPY; TREATMENT OUTCOME;

EID: 84880759916     PISSN: 21686181     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaoto.2013.3387     Document Type: Article

References (31)

1. Gibson MK, Forastiere AA. Multidisciplinary approaches in the management of advanced head and neck tumors: state of the art. Curr Opin Oncol. 2004;16(3):220-224.
2. Agarwal JP, Gupta T, Kalyani N, et al. Cetuximab with radiotherapy in patients with loco-regionally advanced squamous cell carcinoma of head and neck unsuitable or ineligible for concurrent platinum-based chemo-radiotherapy: ready for routine clinical practice? Indian J Cancer. 2011;48(2):148-153.
3. Zafereo ME, Hanasono MM, Rosenthal DI, et al. The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer. 2009;115(24):5723-5733.
4. Oksuz DC, Prestwich RJ, Carey B, et al. Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy. Radiat Oncol. 2011;6:e54. www.ncbi.nlm.nih.gov/pmc/ articles/PMC3127781/.Accessed May 17, 2013.
5. Licitra L, Vermorken JB. Is there still a role for neoadjuvant chemotherapy in head and neck cancer? Ann Oncol. 2004;15(1):7-11.
6. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol. 1992;55(1):145-157.
7. Henderson BW, Bellnier DA. Tissue localization of photosensitizers and the mechanism of photodynamic tissue destruction. Ciba Found Symp. 1989;146:112-130.
8. Brown SB, Brown EA,Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 2004;5(8):497-508.
9. Wilson BC, Patterson MS. The physics, biophysics and technology of photodynamic therapy. Phys Med Biol. 2008;53(9):R61-R109.
10. Karakullukcu B, van Oudenaarde K, Copper MP, et al. Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients. Eur Arch Otorhinolaryngol. 2011;268(2):281-288.
11. Lou PJ, Jäger HR, Jones L, Theodossy T, Bown SG, Hopper C. Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br J Cancer. 2004;91(3):441-446.
12. Lajer CB, Specht LK, Kirkegaard J, Homøe P. Photodynamic therapy for head and neck cancer [in Danish]. Ugeskr Laeger. 2006;168(23):2227-2231.
13. BielMA. Photodynamic therapy of head and neck cancers. Methods Mol Biol. 2010;635:281-293.
14. Bellnier DA, Greco WR, Loewen GM, et al. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients. Cancer Res. 2003;63(8):1806-1813.
15. Lobel J, MacDonald IJ, CiesielskiMJ, et al. 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapy. Lasers Surg Med. 2001;29(5):397-405.
16. Zumsteg A, Christofori G. Corrupt policemen: inflammatory cells promote tumor angiogenesis. Curr Opin Oncol. 2009;21(1):60-70.
17. Loewen GM, Pandey R, Bellnier D, Henderson B, Dougherty T. Endobronchial photodynamic therapy for lung cancer. Lasers Surg Med. 2006;38(5): 364-370.
18. Bellnier DA, Greco WR, Nava H, Loewen GM, Oseroff AR, Dougherty TJ.Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy. Cancer Chemother Pharmacol. 2006;57(1):40-45.
19. Lin Y, ShihWJ. Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials. Biostatistics. 2001;2(2): 203-215.
20. Nava HR, Allamaneni SS, Dougherty TJ, et al. Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagus. Lasers Surg Med. 2011;43(7): 705-712.
21. Ethirajan M, Chen Y, Joshi P, Pandey RK. The role of porphyrin chemistry in tumor imaging and photodynamic therapy. Chem Soc Rev. 2011;40(1): 340-362.
22. BielMA. Photodynamic therapy treatment of early oral and laryngeal cancers. Photochem Photobiol. 2007;83(5):1063-1068.
23. Rigual NR, Thankappan K, Cooper M, et al. Photodynamic therapy for head and neck dysplasia and cancer. Arch Otolaryngol Head Neck Surg. 2009;135(8):784-788.
24. Nathan CO, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients. Laryngoscope. 2002;112(12):2129-2140.
25. Spiro RH, Guillamondegui O Jr, Paulino AF, Huvos AG. Pattern of invasion and margin assessment in patients with oral tongue cancer. Head Neck. 1999;21(5):408-413.
26. Gauthier P, Audet N, Guertin L, et al. Complete frozen section margins (with measurable 1 or 5mm thick free margin) for cancer of the tongue, part 2: clinical experience. J Otolaryngol Head Neck Surg. 2010;39(1):20-27.
27. Nason RW, Binahmed A, Pathak KA, Abdoh AA, Sándor GK. What is the adequate margin of surgical resection in oral cancer? Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(5):625-629.
28. Sewnaik A, Keereweer S, Al-Mamgani A, et al. High complication risk of salvage surgery after chemoradiation failures. Acta Otolaryngol. 2012;132(1):96-100.
29. Tracy EC, Bowman MJ, Pandey RK, Henderson BW, Baumann H. Cell-type selective phototoxicity achieved with chlorophyll-a derived photosensitizers in a co-culture system of primary human tumor and normal lung cells. Photochem Photobiol. 2011;87(6):1405-1418.
30. BielM. Advances in photodynamic therapy for the treatment of head and neck cancers. Lasers Surg Med. 2006;38(5):349-355.
31. BielMA. Photodynamic therapy as an adjuvant intraoperative treatment of recurrent head and neck carcinomas. Arch Otolaryngol Head Neck Surg. 1996;122(11):1261-1265.